Introduction: Early Development of Nucleoside Markers for Cancer

Journal of Chromatography Library

Volumn 46, Issue C, 1990, Pages

  Waalkes, T Phillip ^a   Gehrke, Charles W ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957662833     PISSN: 03014770     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0301-4770(08)61538-9     Document Type: Article

References (42)

1. E. Borek Introduction to symposium; tRNA and tRNA modification in differentiation and neoplasia Cancer Res. 31 1971 596 597
2. B. Weissman P.A. Bromberg A.B. Gutman The purine bases of human urine I. Separation and identification J. Biol. Chem. 224 1957 407 422
3. J.E. Mrochek S.R. Dinsmore T.P. Waalkes Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: Application to urine samples from cancer patients J. Natl. Cancer Inst. 53 1974 1553 1563
4. T.P. Waalkes S.R. Dinsmore J.E. Mrochek Urinary excretion by cancer patients of the nucleosides N2′ N2 dimethylguanosine, 1-methylinosine, and pseudouridine J. Natl. Cancer Inst. 51 1973 271 274
5. T.P. Waalkes C.W. Gehrke R.W. Zumwalt S.Y. Chang D.B. Lakings D.C. Tormey D.L. Ahmann C.G. Moertel The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer Cancer 36 1975 390 398
6. M. Uziel L.H. Smith S.A. Taylor Modified nucleosides in urine: Selective removal and analysis Clin. Chem. 22 1976 145
7. C.W. Gehrke C.D. Ruyle Gas-liquid chromatographic analysis of nucleic acid components J. Chromatogr. 38 1968 473 491
8. D.B. Lakings C.W. Gehrke Gas-liquid chromatographic analysis for purine and pyrimidine bases in hydrolysates of nucleic acid Clin. Chem. 18 1972 810 813
9. S.Y. Chang D.B. Lakings R.W. Zumwalt C.W. Gehrke T.P. Waalkes Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography J. Lab. and Clin. Med. 83 1974 816 830
10. G.E. Davis R.D. Suits K.C. Kuo C.W. Gehrke T.P. Waalkes E. Borek High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids Clin. Chem. 23 1977 1427 1435
11. K.C. Kuo C.W. Gehrke R.A. McCune T.P. Waalkes E. Borek Rapid, quantitative high performance liquid chromatography of pseudouridine J. Chromatogr. 145 1978 383 392
12. C.W. Gehrke K.C. Kuo G.E. Davis R.D. Suits T.P. Waalkes E. Borek Quantitative high performance liquid chromatography of nucleosides in biological materials J. Chromatogr. 150 1978 455 476
13. O.K. Sharma T.P. Waalkes C.W. Gehrke E. Borek Applications of urinary nucleosides in cancer diagnosis and cancer management Cancer Detect, and Prevent. 6 1983 77 85
14. T.P. Waalkes C.W. Gehrke D.B. Lakings R.W. Zumwalt K.C. Kuo S.A. Jacobs E. Borek Brief communication: Beta-aminoisobutyric acid in patients with Burkitt's lymphoma J. Natl. Cancer Inst. 57 1976 435 438
15. K.C. Kuo T.F. Cole C.W. Gehrke T.P. Waalkes E. Borek Dual-column cation-exchange chromatographic method for β aminoisobutyric acid and βalanine in biological samples Clin. Chem. 24 1978 1373 1380
16. K.B. Woo T.P. Waalkes D.L Ahmann D.C. Tormey C.W. Gehrke V.T. Oliverio A quantitative approach to determining disease response during therapy using multiple biological markers. Application to carcinoma of the breast Cancer 41 1978 1871 1882
17. R.C. Coombes T.J. Powles C.W. Gehrke T.P. Waalkes A.M. Neville Nucleoside excretion in breast cancer: Comparison with other biochemical tumour-index substances Investigative and Cell Pathology 2 1979 11 14
18. C.W. Gehrke K.C. Kuo R.W. Zumwalt Chromatography of nucleosides J. Chromatogr. 188 1980 129 147
19. C.W. Gehrke K.C. Kuo R.A. McCune K.O. Gerhardt Quantitative enzymatic hydrolysis of tRNAs: Reversed-phase high performance liquid chromatography of tRNA nucleosides J. Chromatogr. 230 1982 297 308
20. T.P. Waalkes M.D. Abeloff D.S. Ettinger K.B. Woo C.W. Gehrke J.E. Mrochek Multiple biological markers and breast carcinoma: A Preliminary stuy in the detection of recurrent disease after primary therapy,” J Surg. Oncol. 18 1981 9 19
21. T.P. Waalkes M.D. Abeloff D.S. Ettinger K.B. Woo C.W. Gehrke K.C. Kuo E. Borek Biological markers and small cell carcinoma of the lung: A clinical evaluation of urinary ribonucleosides Cancer 50 1982 2457 2464
22. T.P. Waalkes M.D. Abeloff D.S. Ettinger K.B. Woo C.W. Gehrke K.C. Kuo E. Borek Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lung Eur. J. Cancer & Clin. Oncol. 18 1982 1267 1274
23. T.P. Waalkes M. Rosenshein J.H. Shaper D.S. Ettinger K.B. Woo J.F. Paone C.W. Gehrke A feasibility study in the development of biological markers for ovarian cancer J. Surg. Oncol. 2 1982 207 214
24. E. Borek T.P. Waalkes C.W. Gehrke Tumor markers derived from nucleic acid components Cancer Detect, and Prevent. 6 1983 67 71
25. C.W. Gehrke K.C. Kuo High resolution quantitative high performance liquid chromatography-UV-spectrometry analysis of nucleosides in tRNA, mRNA, DNA, and physiological fluids Bull. Mol. Biol. Med. 10 1985 119 142
26. C.W. Gehrke, K.C. Kuo, Ribonucleoside analysis by reversed-phase high performance liquid chromatography, submitted Nov. 1988 J. Chromatogr.
27. K.C. Kuo F. Esposito J.E. McEntire C.W. Gehrke Nucleoside profiles by HPLC-UV in serum and urine of controls and cancer patients F. Cimino G.D. Birkmayer J.V. Klavins E. Pimentel F. Salvatore Human Tumor Markers 1987 Walter de Gruyter Berlin-New York 519 544
28. C.W. Gehrke, K.C. Kuo, High resolution quantitative RP-HPLC-UV of nucleosides in RNA, Human Tumor Markers, 1987 pp. 475–502.
29. T. Rasmuson G.R. Bjork L. Damber S.E. Holm L. Jacobsson A. Jeppsson B. Littbrand T. Stigbrand G. Westman Evaluation of carcinoembryonic antigen, tissue peptie antigen, placenta alkaline phosphatase and modified nucleosides as biological markers in malignant lymphomas G. Nass Recent Results in Cancer Research 84 1983 Springer-Verlag Berlin-New York 331 343
30. R.A. Hartwick S.P Assenza P.R. Brown Identification and quantitation of nucleosides, bases, and other UV-absorbing compounds in serum using RP-HPLC. I. Chromatographic methods J. Chromatogr. 186 1979 648 658
31. R.A. Hartwick A.M. Krstulovic P.R. Brown Identification and quantitation of nucleosides, bases, and other UV-absorbing compounds in serum using RP-HPLC. II. Evaluation of human sera J. Chromatogr. 186 1979 659 676
32. F. Cimino T. Russo A. Colonna A. Duilio R. Ammendola F. Costanzo A. Oliva F. Esposito F. Salvatore Pseudouridine excretion in experimental neoplasias of retroviral origin F. Cimino G.D. Birkmayer J.V. Klavins E. Pimentel F. Salvatore Human Tumor Markers 1987 Walter de Gruyter Berlin-New York 463 474
33. I. Clark J.W. MacKenzie J.R. McCoy W. Win Comparison of urinary modified nucleosides and bases in rats with hepatomas and nephroblastomas G. Nass Recent Results in Cancer Research 84 1983 Springer-Verlag Berlin-New York 388 400
34. J.E. McEntire, K.C. Kuo, M.E. Smith, D.L Stalling, J.W. Richens, Jr., R.W. Zumwalt, C.W. Gehrke, B.W. Papermaster, Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum, Cancer Res., Accepted Nov. 1988.
35. F. Salvatore M. Savoia T. Russo L. Sacchetti F. Cimino Pseudouridine in biological fluids of tumor-bearing patients F. Cimino G.D. Birkmayer J.V. Klavins E. Pimentel F. Salvatore Human Tumor Markers 1987 Walter de Gruyter Berlin-New York 451 462
36. O.K. Sharma F.L. Buschman E. Borek D.L. Cohn K.A. Penley F.N. Judson B.S. Dobozin K.M. Zunich C.H. Kirkpatrick Aberrant urinary excretion of modified nucleosides in patients with various manifestations of infection with HTLV-III/LAV F. Cimino G.D. Birkmayer J.V. Klavins E. Pimentel F. Salvatore Human Tumor Markers 1987 Walter de Gruyter Berlin-New York 545 558
37. E. Schlimme K.-S. Boos B. Wilmers H.J. Gent Analysis of ribonucleosides in human body fluids and their possible role as pathobiochemical markers F. Cimino G.D. Birkmayer J.V. Klavins E. Pimentel F. Salvatore Human Tumor Markers 1987 Walter de Gruyter Berlin-New York 503 517
38. G. Sander J. Wieland H. Topp G. Heller-Schöch N. Erb G. Schöch An improved method for the simultaneous analysis of normal and modified urinary nucleosides and nucleobases by high-performance liquid chromatography Clin. Chim, Acta 152 1985 355 361
39. S. Tamura J. Fujii N. Takaski H. Toshikazu H. Kazuyu Urinary pseudouridine as a tumor marker in patients with small cell lung cancer Clin. Chim. Acta 154 1986 125 132
40. R.W. Trewyn M.R. Grever Urinary nucleosides in leukemia: laboratory and clinical applications, CRC Critical Rev Clin. Lab. Sci. 24 1986 71 93
41. F. Salvatore, L. Sacchetti, F. Pane, K.C. Kuo, C.W. Gehrke, Clinical Evaluation of Serum Nucleosides in Leukemias and Lymphomas. In Preparation.
42. K.C. Kuo, D.T. Phan, N. Williams, C.W. Gehrke, Ribonucleosides in serum and urine by a high-resolution quantitative RPLC-UV method. Submitted to J. Chromatogr. Biomedical Applications.